Canopy FGF signaling regulator 3 affects prognosis, immune infiltration, and PI3K/AKT pathway in colon adenocarcinoma

Figure 1 Expression levels of canopy FGF signaling regulator 3 in pan-cancer and Cancer Genome Atlas colon adenocarcinoma cohort. A: Canopy FGF signaling regulator 3 (CNPY3) was highly expressed in several digestive system cancers; B: CNPY3 was highly expressed in Cancer Genome Atlas (TCGA)-colon adenocarcinoma cohort; C: CNPY3 was highly expressed in merged dataset (Genotype Tissue Expression normal, TCGA normal, and TCGA cancer); D: Heatmap of associations between CNPY3 expression and clinicopathological features; E: Correlation between CNPY3 expression and T stage. F: Correlation between CNPY3 expression and M stage; G: Correlation between CNPY3 expression and N stage. ^aP < 0.05; ^bP < 0.01, ^cP < 0.001. CNPY3: Canopy FGF signaling regulator 3; TCGA: The Cancer Genome Atlas; COAD: Colon adenocarcinoma; GTEx: Genotype Tissue Expression.